NCT05223673
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05223673 |
| Title | Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer (COLSTAR) |
| Acronym | COLSTAR |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Institut de Recherches Internationales Servier |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | HUN | FIN | DNK | BEL |
CKB BOOST